Quarterly Put Option Transactions in Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP). The information is specifically focused on institutions that hold put options of CRISPR Therapeutics AG.
Puts Purchased
Puts Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 281,400 | 89,300 | 370,700 | 209,300 | 43,500 | 252,800 | 117,900 | |
Q4 2021 | 205,600 | 15,002 | 220,602 | 483,300 | 217,200 | 700,500 | -479,898 | |
Q1 2022 | 292,000 | 12,400 | 304,400 | 342,300 | 0 | 342,300 | -37,900 | |
Q2 2022 | 699,600 | 143,500 | 843,100 | 74,600 | 0 | 74,600 | 768,500 | |
Q3 2022 | 596,500 | 205,700 | 802,200 | 483,000 | 0 | 483,000 | 319,200 | |
Q4 2022 | 279,800 | 66,600 | 346,400 | 411,400 | 0 | 411,400 | -65,000 | |
Q1 2023 | 245,500 | 36,700 | 282,200 | 788,400 | 0 | 788,400 | -506,200 | |
Q2 2023 | 279,500 | 480,100 | 759,600 | 351,200 | 0 | 351,200 | 408,400 | |
Q3 2023 | 56,200 | 64,100 | 120,300 | 394,961 | 0 | 394,961 | -274,661 | |
Q4 2023 | 2,374,661 | 493,200 | 2,867,861 | 218,600 | 0 | 218,600 | 2,649,261 | |
Q1 2024 | 274,400 | 270,300 | 544,700 | 1,056,200 | 0 | 1,056,200 | -511,500 | |
Q2 2024 | 23,500 | 38,300 | 61,800 | 585,600 | 0 | 585,600 | -523,800 | |
Q3 2024 | 159,200 | 166,700 | 325,900 | 109,700 | 0 | 109,700 | 216,200 |